Trial intelligence / Profile preview

Oral Fentanyl vs Midazolam Premedication in Pediatric Cardiac Surgery

NCT04991298Unknown

Sponsor
Alexandria University
Start
Jun 2021
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of fentanyl (transdermal patch + oral transmucosal lozenge) in congenital heart disease (CHD) (2 arms), sponsored by Alexandria University. Primary endpoints: Patient's acceptance of the medication at 1 year, Reaction to separation from parents at 1 year and 2 more. Status: unknown.

02

Drugs

fentanyl (transdermal patch + oral transmucosal lozenge)
03

Conditions

congenital heart disease (CHD)

Beyond the preview

Go deeper on NCT04991298.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04991298.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call